Literature DB >> 31482156

Are drug-related dental management cautions in Lexicomp Online for Dentistry evidence-based? A systematic review of the literature.

Ayesha Qadeer, Temitope T Omolehinwa, Mel Mupparapu, Sunday O Akintoye.   

Abstract

OBJECTIVES: Drug reference databases provide information on potential drug-related medical complications in a dental patient. It is important that database entries and recommendations are supported by evidence-based original studies focused on drug-related dental management complications. The aim of this study was to review and identify database drug categories associated with evidence-based drug-related medical complications during dental treatment. DATA SOURCES: Relevant publications on adverse drug reactions and dental management complications were thoroughly reviewed from the literature published between July 1975 and July 2019. METHOD AND MATERIALS: The drug reference database "Lexicomp Online for Dentistry" was reviewed to identify medications associated with the highest propensity to trigger drug-related dental management complications, and these were correlated with published original studies in PubMed, Embase, and Scopus databases that associated drug actions with dental treatment complications.
RESULTS: Fifty-four publications (1.2% of all full-text articles) reported original studies that directly tested drug associations with dental management complications. The cautions in the drug reference database on drug-related dental treatment mainly focused on local anesthetic precaution (P < .001), xerostomia (P < .001), bleeding (P < .001), and a combination of xerostomia and bleeding (P < .001). Antipsychotics/antidepressants were mostly associated with local anesthetic complications (80.95%), xerostomia (81.93%), and a combination of xerostomia and bleeding (22.89%). Bleeding complication was associated with anticoagulants (80.00%) and cancer chemotherapeutic agents (59.21%).
CONCLUSIONS: Similarities exist within and across different drug categories in the database entries on drug-related medical complications in a dental patient. There were a relatively limited number of publications that directly tested the association between drug-related medical complications and dental therapies. CLINICAL RELEVANCE: The most common drug cautions during dental treatment reported in Lexicomp Online for Dentistry were limited to drug-drug interactions with local anesthetic actions, excessive bleeding, xerostomia, or a combination of any of these. These recommendations were supported by limited evidence-based studies.

Entities:  

Keywords:  bleeding; dental treatment planning; drug effects; medical complications; xerostomia

Mesh:

Substances:

Year:  2019        PMID: 31482156      PMCID: PMC8088457          DOI: 10.3290/j.qi.a43090

Source DB:  PubMed          Journal:  Quintessence Int        ISSN: 0033-6572            Impact factor:   1.677


  31 in total

Review 1.  Bleeding risks of herbal, homeopathic, and dietary supplements: a hidden nightmare for plastic surgeons?

Authors:  Wendy W Wong; Allen Gabriel; G Patrick Maxwell; Subhas C Gupta
Journal:  Aesthet Surg J       Date:  2012-03       Impact factor: 4.283

Review 2.  Review of herbal medications with the potential to cause bleeding: dental implications, and risk prediction and prevention avenues.

Authors:  Worku Abebe
Journal:  EPMA J       Date:  2019-01-08       Impact factor: 6.543

3.  The 'top 100' drugs and classes in England: an updated 'starter formulary' for trainee prescribers.

Authors:  Selma Audi; Daniel R Burrage; Dagan O Lonsdale; Sarah Pontefract; Jamie J Coleman; Andrew W Hitchings; Emma H Baker
Journal:  Br J Clin Pharmacol       Date:  2018-08-10       Impact factor: 4.335

4.  AAOM clinical practice statement: Subject: The use of serum C-terminal telopeptide cross-link of type 1 collagen (CTX) testing in predicting risk of osteonecrosis of the jaw (ONJ).

Authors: 
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2017-09-06

5.  Herbal supplement use among adult dental patients in a USA dental school clinic: prevalence, patient demographics, and clinical implications.

Authors:  Worku Abebe; Wayne Herman; Joseph Konzelman
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-01-07

6.  Bleeding complications following Nd:YAG laser-assisted oral surgery vs conventional treatment in cardiac risk patients: a clinical retrospective comparative study.

Authors:  Herbert Deppe; Thomas Mücke; Julia Auer-Bahrs; Stefan Wagenpfeil; Marco Kesting; Anton Sculean
Journal:  Quintessence Int       Date:  2013-07       Impact factor: 1.677

7.  The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants.

Authors:  Erin Salkeld; Lorraine E Ferris; David N Juurlink
Journal:  J Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.153

Review 8.  Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment.

Authors:  Nitin Toteja; Juan A Gallego; Ema Saito; Tobias Gerhard; Almut Winterstein; Mark Olfson; Christoph U Correll
Journal:  Int J Neuropsychopharmacol       Date:  2013-05-14       Impact factor: 5.176

9.  Xerostomia and lichenoid reaction in a hepatitis C patient treated with interferon-alpha: a case report.

Authors:  Junu Ojha; Indraneel Bhattacharyya; Nadim Islam; Donald M Cohen; Carol M Stewart; Joseph Katz
Journal:  Quintessence Int       Date:  2008-04       Impact factor: 1.677

10.  Adverse drug and device reactions in the oral cavity: surveillance and reporting.

Authors:  Athanasios I Zavras; Gregory E Rosenberg; Jared D Danielson; Vassiliki M Cartsos
Journal:  J Am Dent Assoc       Date:  2013-09       Impact factor: 3.634

View more
  1 in total

1.  A cell-based high-throughput screen identifies drugs that cause bleeding disorders by off-targeting the vitamin K cycle.

Authors:  Xuejie Chen; Caihong Li; Da-Yun Jin; Brian Ingram; Zhenyu Hao; Xue Bai; Darrel W Stafford; Keping Hu; Jian-Ke Tie
Journal:  Blood       Date:  2020-08-13       Impact factor: 25.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.